Cooper C. Collins, Director at TherapeuticsMD, Inc. (TXMD), bought 74,000 shares at $1.45 ($107K) on 2020-06-09, disclosed to the SEC on 2020-06-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.45 | 26,500 | $38K | 35.8% |
| 2 | $1.45 | 47,500 | $69K | 64.2% |
| Total | $1.45 avg | 74,000 | $107K | 100% |
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2019-05-15 | $100K | — | Filing → |